Two Sigma Advisers
TRAW icon

Two Sigma Advisers’s Traws Pharma TRAW Stock Holding History

Two Sigma Advisers’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,923
Closed -$73.8K – 2707
2024
Q1 		$73.8K Sell
2,923
-196
-6% -$3.78K ﹤0.01% 2323
2023
Q4 		$58.1K Sell
3,119
-675
-18% -$11.5K ﹤0.01% 2388
2023
Q3 		$67.5K Sell
3,794
-1,940
-34% -$44.3K ﹤0.01% 2250
2023
Q2 		$169K Buy
5,734
+4,664
+436% +$125K ﹤0.01% 2128
2023
Q1 		$19.5K Sell
1,070
-936
-47% -$20.3K ﹤0.01% 2519
2022
Q4 		$32.4K Sell
2,006
-3,040
-60% -$57.3K ﹤0.01% 2396
2022
Q3 		$111K Sell
5,046
-2,110
-29% -$63.8K ﹤0.01% 2295
2022
Q2 		$236K Sell
7,156
-6,936
-49% -$234K ﹤0.01% 2215
2022
Q1 		$648K Buy
14,092
+2,280
+19% +$106K ﹤0.01% 1855
2021
Q4 		$753K Buy
+11,812
New +$950K ﹤0.01% 1713
2021
Q3 		– Sell
-625
Closed -$108K – 2714
2021
Q2 		$108K Buy
625
+302
+93% +$68.3K ﹤0.01% 2339
2021
Q1 		$121K Buy
+323
New +$122K ﹤0.01% 2425
2020
Q4 		– Sell
-52
Closed -$5K – 2632
2020
Q3 		$5K Buy
+52
New +$12.9K ﹤0.01% 2373

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers's TRAW Position: Q2 2024 in Review

Two Sigma Advisers sold out of Traws Pharma (TRAW) in Q2 2024, closing a stake of 2,923 shares — an estimated $73.8K sold.

Two Sigma Advisers first reported a position in TRAW in Q3 2020 and held it in 13 quarters. The position peaked at $753K in Q4 2021. 28 funds tracked by Wall St. Rank hold TRAW as of Q2 2024.

  • Two Sigma Advisers reported no remaining Traws Pharma position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 2,923 Traws Pharma shares in Q2 2024, an estimated $73.8K.
  • Two Sigma Advisers first reported a position in Traws Pharma in Q3 2020 and held it in 13 quarters.
  • Two Sigma Advisers's Traws Pharma position peaked at $753K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.